|Articles|June 4, 2013
Dr Sharon Discusses How Insurers Have Responded to the Availability of Therapies for RLS
In this video, Denise Sharon, MD, PhD, Clinical Director and Founding Partner, Comprehensive Sleep Medicine Center of the Gulf Coast, discusses how insurers have responded to the availability of therapies and changes in clinical practice guidelines for RLS.
Advertisement
In this video, Denise Sharon, MD, PhD, Clinical Director and Founding Partner, Comprehensive Sleep Medicine Center of the Gulf Coast, discusses how insurers have responded to the availability of therapies and changes in clinical practice guidelines for RLS.
This video was taken on June 4, 2013, at the Sleep 2013 Meeting in Baltimore, MD.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
2
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
3
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
4
Cleveland Panel Weighs New HFpEF Pathway, Access to Finerenone
5